Inhibitors of Sphingolipid Metabolism
A85392 (857392) (R)-FTY720-OMe
ViewA85393 (857393) THI
ViewA85494 (857395) GT-11
ViewA86455 (860455) N-C12-deoxysphingosine
ViewA86456 (860456) N-C16-deoxysphingosine
ViewA86461 (860461) N-C12-desoxymethylsphinganine
ViewA86466 (860466) N-C12-desoxymethylsphingosine
ViewA86462 (860462) N-C16-deoxysphinganine
ViewA86463 (860463) N-C16-desoxymethylsphinganine
ViewA86467 (860467) N-C16-desoxymethylsphingosine
ViewA86464 (860464) N-C24:1-deoxysphinganine
ViewA86457 (860457) N-C24:1-deoxysphingosine
ViewA86465 (860465) N-C24:1-desoxymethylsphinganine
ViewA86468 (860468) N-C24:1-desoxymethylsphingosine
ViewA86493 (860493) 1-deoxysphinganine
ViewA86470 (860470) 1-deoxysphingosine
ViewA86473 (860473) 1-desoxymethylsphinganine
ViewA86477 (860477) 1-desoxymethylsphingosine
ViewA86479 (860479) Adamantanyl Galactosyl(ß) Ceramide
ViewA86480 (860480) C10 bisphosphonate
ViewA86488 (860488) Safingol
ViewA86771 (860771) Enigmol(2S,3S,5S)
ViewA86772 (860772) N-C6-Enigmol(2S,3S,5S)
ViewA86792 (860792) C23 Galactosyl(ß) Ceramide (d18:1/23:0)
ViewLewis, A.C., Wallington-Beddoe, C.T., Powell, J.A., et al. Targeting sphingolipid metabolism as an approach for combination therapies in hematological malignancies. Cell Death Discov. 4, 72 (2018). https://doi.org/10.1038/s41420-018-0075-0